Clinical Research to examine the efficacy and safety of Certolizmab pegol

Clinical Research to examine the efficacy and safety of Certolizmab pegol - Clinical Research to examine the efficacy and safety of Certolizmab pegol

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010664

Enrollment

100

Registered

2013-06-30

Start date

2013-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)The patient who is diagnosed as rheumatoid arthritis according to ACR criteria in 1987 or ACR/EULAR new classification criteria in 2010. 2)The patient falling under any of a) or b). a)The patient who is on CZP administration. b)The patient whose doctor is planning novel CZP administration 3)The patient who obtained a written consent.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Percentage of the subjects who achieved the remission of DAS28-ESR/CRP at the point of W24	—

Countries

Japan

Outcome results